Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,950 | 7 | 93.7% |
| Food and Beverage | $131.69 | 5 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tandem Diabetes Care, Inc. | $1,950 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $56.68 | 2 | $0 (2018) |
| Radius Health, Inc. | $49.54 | 1 | $0 (2024) |
| Shire North American Group Inc | $14.58 | 1 | $0 (2018) |
| Animas Corporation | $10.89 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.54 | 1 | Radius Health, Inc. ($49.54) |
| 2018 | $1,471 | 8 | Tandem Diabetes Care, Inc. ($1,400) |
| 2017 | $560.89 | 3 | Tandem Diabetes Care, Inc. ($550.00) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $49.54 | General |
| Category: Endocrinology | ||||||
| 11/28/2018 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Endocrinology | ||||||
| 10/24/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2018 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Endocrinology | ||||||
| 07/26/2018 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Endocrinology | ||||||
| 03/21/2018 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Endocrinology | ||||||
| 02/07/2018 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Endocrinology | ||||||
| 01/11/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.62 | General |
| 01/04/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $33.06 | General |
| 11/03/2017 | Animas Corporation | OneTouch (Device) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Diabetes | ||||||
| 10/11/2017 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Endocrinology | ||||||
| 01/18/2017 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 301 | 368 | $149,251 | $32,986 |
| 2022 | 6 | 214 | 265 | $122,975 | $27,771 |
| 2021 | 8 | 272 | 308 | $111,599 | $24,539 |
| 2020 | 26 | 1,342 | 4,448 | $280,262 | $90,242 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 163 | $69,764 | $15,785 | 22.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $38,324 | $8,226 | 21.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 29 | $17,400 | $3,946 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 31 | $9,393 | $1,926 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,696 | $1,379 | 20.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 32 | 39 | $4,485 | $1,075 | 24.0% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 15 | 15 | $1,785 | $391.56 | 21.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 23 | 27 | $1,404 | $257.04 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 74 | 74 | $54,168 | $12,271 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 115 | $48,760 | $11,351 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $8,310 | $1,629 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 25 | $7,525 | $1,494 | 19.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 11 | 18 | $2,070 | $516.88 | 25.0% |
| 99451 | Telephone or internet assessment with written report by consulting physician, 5 minutes or more | Office | 2022 | 18 | 18 | $2,142 | $510.27 | 23.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 95 | $38,689 | $8,290 | 21.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 48 | 48 | $35,328 | $8,201 | 23.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $25,065 | $5,409 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 30 | $8,433 | $1,659 | 19.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 13 | 20 | $2,311 | $437.74 | 18.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 26 | 27 | $967.00 | $262.17 | 27.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 11 | 11 | $550.00 | $184.80 | 33.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 32 | 32 | $256.00 | $96.00 | 37.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 35 | 2,580 | $75,149 | $39,433 | 52.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 168 | 255 | $85,935 | $19,264 | 22.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 40 | 40 | $25,600 | $5,814 | 22.7% |
About Dr. Stephen Mitchell, DO
Dr. Stephen Mitchell, DO is a Endocrinology, Diabetes & Metabolism healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164521654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Mitchell, DO has received a total of $2,082 in payments from pharmaceutical and medical device companies, with $49.54 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,950).
As a Medicare-enrolled provider, Mitchell has provided services to 2,129 Medicare beneficiaries, totaling 5,389 services with total Medicare billing of $175,538. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Portland, OR
- Active Since 09/21/2006
- Last Updated 10/11/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1164521654
Products in Payments
- t-slim insulin pump (Device) $1,950
- Tymlos (Drug) $49.54
- VYVANSE (Drug) $14.58
- OneTouch (Device) $10.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Portland
Mr. Michael Mcclung, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.6M
James Neifing, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $475,019
Maria Fleseriu, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $418,716
Rodica Busui, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $211,479
Jonathan Purnell, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $209,631
Nancy Curosh, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $194,307